• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Genet . Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and Afri

tetano

Editor, Senior Moderator
Nat Genet


. 2022 Jul 14.
doi: 10.1038/s41588-022-01113-z. Online ahead of print.
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries


A Rouf Banday[SUP] #[/SUP][SUP] 1 [/SUP], Megan L Stanifer[SUP] #[/SUP][SUP] 2 3 [/SUP], Oscar Florez-Vargas[SUP] #[/SUP][SUP] 1 [/SUP], Olusegun O Onabajo[SUP] 1 [/SUP], Brenen W Papenberg[SUP] 1 [/SUP], Muhammad A Zahoor[SUP] 4 [/SUP], Lisa Mirabello[SUP] 5 [/SUP], Timothy J Ring[SUP] 1 [/SUP], Chia-Han Lee[SUP] 1 [/SUP], Paul S Albert[SUP] 6 [/SUP], Evangelos Andreakos[SUP] 7 [/SUP], Evgeny Arons[SUP] 8 [/SUP], Greg Barsh[SUP] 9 [/SUP], Leslie G Biesecker[SUP] 10 [/SUP], David L Boyle[SUP] 11 [/SUP], Mark S Brahier[SUP] 12 [/SUP], Andrea Burnett-Hartman[SUP] 13 [/SUP], Mary Carrington[SUP] 14 15 16 [/SUP], Euijin Chang[SUP] 17 [/SUP], Pyoeng Gyun Choe[SUP] 17 [/SUP], Rex L Chisholm[SUP] 18 [/SUP], Leandro M Colli[SUP] 19 [/SUP], Clifton L Dalgard[SUP] 20 [/SUP], Carolynn M Dude[SUP] 21 [/SUP], Jeff Edberg[SUP] 22 [/SUP], Nathan Erdmann[SUP] 23 [/SUP], Heather S Feigelson[SUP] 13 [/SUP], Benedito A Fonseca[SUP] 24 [/SUP], Gary S Firestein[SUP] 11 [/SUP], Adam J Gehring[SUP] 4 25 [/SUP], Cuncai Guo[SUP] 26 [/SUP], Michelle Ho[SUP] 1 [/SUP], Steven Holland[SUP] 27 [/SUP], Amy A Hutchinson[SUP] 28 [/SUP], Hogune Im[SUP] 29 [/SUP], Les'Shon Irby[SUP] 21 [/SUP], Michael G Ison[SUP] 30 [/SUP], Naima T Joseph[SUP] 31 [/SUP], Hong Bin Kim[SUP] 17 32 [/SUP], Robert J Kreitman[SUP] 8 [/SUP], Bruce R Korf[SUP] 33 [/SUP], Steven M Lipkin[SUP] 34 [/SUP], Siham M Mahgoub[SUP] 35 [/SUP], Iman Mohammed[SUP] 36 [/SUP], Guilherme L Paschoalini[SUP] 19 [/SUP], Jennifer A Pacheco[SUP] 18 [/SUP], Michael J Peluso[SUP] 37 [/SUP], Daniel J Rader[SUP] 38 [/SUP], David T Redden[SUP] 39 [/SUP], Marylyn D Ritchie[SUP] 38 [/SUP], Brooke Rosenblum[SUP] 10 [/SUP], M Elizabeth Ross[SUP] 36 [/SUP], Hanaisa P Sant Anna[SUP] 40 [/SUP], Sharon A Savage[SUP] 5 [/SUP], Sudha Sharma[SUP] 41 [/SUP], Eleni Siouti[SUP] 7 [/SUP], Alicia K Smith[SUP] 21 [/SUP], Vasiliki Triantafyllia[SUP] 7 [/SUP], Joselin M Vargas[SUP] 1 [/SUP], Jose D Vargas[SUP] 42 [/SUP], Anurag Verma[SUP] 38 [/SUP], Vibha Vij[SUP] 43 [/SUP], Duane R Wesemann[SUP] 44 [/SUP], Meredith Yeager[SUP] 28 [/SUP], Xu Yu[SUP] 16 [/SUP], Yu Zhang[SUP] 27 [/SUP], Steeve Boulant[SUP] 3 26 45 [/SUP], Stephen J Chanock[SUP] 40 [/SUP], Jordan J Feld[SUP] 4 25 [/SUP], Ludmila Prokunina-Olsson[SUP] 46 [/SUP]



Affiliations

Abstract

The chr12q24.13 locus encoding OAS1-OAS3 antiviral proteins has been associated with coronavirus disease 2019 (COVID-19) susceptibility. Here, we report genetic, functional and clinical insights into this locus in relation to COVID-19 severity. In our analysis of patients of European (n = 2,249) and African (n = 835) ancestries with hospitalized versus nonhospitalized COVID-19, the risk of hospitalized disease was associated with a common OAS1 haplotype, which was also associated with reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clearance in a clinical trial with pegIFN-λ1. Bioinformatic analyses and in vitro studies reveal the functional contribution of two associated OAS1 exonic variants comprising the risk haplotype. Derived human-specific alleles rs10774671-A and rs1131454 -A decrease OAS1 protein abundance through allele-specific regulation of splicing and nonsense-mediated decay (NMD). We conclude that decreased OAS1 expression due to a common haplotype contributes to COVID-19 severity. Our results provide insight into molecular mechanisms through which early treatment with interferons could accelerate SARS-CoV-2 clearance and mitigate against severe COVID-19.
 
Back
Top Bottom